Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

Added 571 days ago (02.11.2020)
Authors: Autio, K. A., Klebanoff, C. A., Schaer, D., Kauh, J. S. W., Slovin, S. F., Adamow, M., Blinder, V. S., Brahmachary, M., Carlsen, M., Comen, E., Danila, D. C., Doman, T. N., Durack, J. C., Fox, J. J., Gluskin, J. S., Hoffman, D. M., Kang, S., Kang, P., Landa, J., McAndrew, P. F., Modi, S., Morris, M. J., Novosiadly, R., Rathkopf, D. E., Sanford, R., Chapman, S. C., Tate, C. M., Yu, D., Wong, P., McArthur, H. L.
Read article